Monday 8/31 — Desk Preview

Prepared Sunday 8/30/26. Landscape only, no recommendations.

The frame

Stocks close out August on a soft note: S&P 500 7,711.76 (-0.25% Friday, +0.5% on the week), Nasdaq 26,402.42 (-0.52%, +0.9% wk), Dow 53,559.99 (flat). The dominant story isn't earnings — it's the Fed. Chair Kevin Warsh used his first Jackson Hole keynote to call inflation "running too high" and put price stability front and center; September hike odds on CME FedWatch spiked to roughly 57% from about 35% the day before. That reframes a week that also brings JOLTS (Tue 9/1), ADP (Wed 9/2), and the August jobs report (Fri 9/4, consensus +58K, unemployment 4.1%, average hourly earnings +0.3%). Layered on top: NVDA's 8/26 print — revenue $96.2B (+106% y/y, ~4.5% beat), EPS $2.22, guidance roughly 4% above Street — still triggered a fourth straight post-print decline, and the SOX has fallen as much as 29% off its late-June record. The tape is interrogating AI-capex payback even when the numbers beat. It's a full trading week (Labor Day is 9/7), but pre-holiday positioning likely means lighter volumes into Friday's jobs data. SAIC is the lone reporter Monday, kicking off a defense-services read before Tuesday's much heavier AI-infrastructure and software slate.

Tier 1 — before the open

SAIC ($125.96) — a beat-and-raise streak meets a tougher sequential compare. Science Applications International reports fiscal Q2 FY27 before Monday's open, with a 10 a.m. ET call. Consensus sits at roughly $2.31 EPS on $1.76B revenue — a sequential step-down from Q1's $3.23 EPS on $1.91B (Q1 beat by ~42% and prompted a guidance raise on FY27 EBITDA margin and free-cash-flow-per-share targets), and year-over-year that consensus implies EPS down ~36% even as revenue holds roughly flat (-0.6%). The stock closed Friday at $125.96 (-2.33% on the day), inside a 52-week range of $81.08-$130.98, carrying a forward P/E of 13.0x and a $1.48 dividend (1.18% yield, with a fresh $0.37/share declared just Friday 8/28). Analyst targets have been chasing the stock higher all summer — Jefferies to $130 from $115, Citi to $132, Stifel to $137, JPMorgan to $125 — but the Street-wide average target is $121.50, below Friday's close, and the consensus rating remains Hold; Goldman is still at Sell with a $96 target. Contract momentum is the offsetting story: Intel Space awards have topped $1.6B in the first half of FY27, including a $400M intelligence-agency recompete in early August, and investors will be watching whether that pipeline can cushion the sequential earnings decline and whether gross margin (last reported near 12.6%) holds up as the mix shifts.

Dominoes

SAIC sets the tone for the government-IT-services complex and is the only print of the week not touched by the AI-capex debate directly — but it's also the calm before a very AI-heavy Tuesday. MDT, MMED, NIO, and YEXT report before Tuesday's open; CRDO, DELL, GTLB, MDB, and PANW report after Tuesday's close, with DELL and CRDO setting up direct reads into Wednesday's AVGO and HPE prints, and PANW setting up Thursday's ZS. See tuesday.md for the full slate.

Flagged as unverified

• SAIC's exact fiscal Q2 FY27 consensus figures ($2.31 EPS / $1.76B revenue) come from a single earnings-preview aggregation rather than a named data provider (e.g., FactSet/Visible Alpha); treat as directional. The Aug-31-before-open timing itself is confirmed by SAIC's own investor-relations press release.
• Short-interest figure for SAIC (~6.8% of float) is from a source that did not carry a clear as-of date; could be stale by a few weeks.

*Sources: SAIC investor relations (globenewswire.com/news-release/2026/08/13), stockanalysis.com, TipRanks (SAIC earnings calendar), Investing.com (SAIC earnings preview), GovConWire, GuruFocus, CNBC (Warsh Jackson Hole coverage), NPR, Bitcoin.com News (FedWatch odds), all accessed 8/30/26.

Tuesday 9/1 — Desk Preview

Prepared Sunday 8/30/26. Landscape only, no recommendations.

The frame

Tuesday is the heaviest print day of the week, sandwiched between a hawkish Fed signal and the August jobs report. Chair Kevin Warsh's Jackson Hole keynote called inflation "running too high," and September rate-hike odds on CME FedWatch jumped to roughly 57% from about 35% the prior day — a genuine repricing that shows up as a headwind for anything trading on a long-duration growth multiple this week. Markets closed out Friday 8/28 with the S&P 500 at 7,711.76 (-0.25% day, +0.5% wk), Nasdaq 26,402.42 (-0.52%, +0.9% wk), Dow 53,559.99 (flat). JOLTS lands Tuesday itself, ADP Wednesday, and the August jobs report Friday 9/4 (consensus +58K, unemployment 4.1%, average hourly earnings +0.3%) — all now read through a more hawkish Fed lens. The other overhang is NVDA: its 8/26 beat (revenue $96.2B, +106% y/y, ~4.5% ahead of Street; EPS $2.22; guidance ~4% above consensus) still produced a fourth consecutive post-print decline, and the SOX has fallen as much as 29% off its late-June record. Estimated industry AI capex is tracking above $1T this year (+~111%), with hyperscaler capex +~98% — so every AI-infrastructure name reporting this week (CRDO, DELL, and to a lesser extent PANW/GTLB/MDB on the agentic-software side) is reporting into a tape that is actively testing whether AI-linked capex converts to durable margin, not just revenue growth. It's a full week with light pre-holiday volumes expected into Labor Day (9/7).

Tier 1 — before the open

MDT ($91.23) — a turnaround thesis meets a clean-looking bar. Medtronic reports fiscal Q1 FY27 before Tuesday's open. Consensus calls for EPS of $1.39 (+10.3% y/y) on revenue of $9.47B (+10.4% y/y); the company has beaten estimates in each of the last four quarters by an average of 2.3%. The stock closed Friday at $91.23 (+1.40%), inside a 52-week range of $73.31-$106.33, trading at a 15.3x forward multiple with a 3.16% dividend yield. Sell-side has turned more constructive into the print — UBS upgraded to Buy from Neutral (target to $100 from $85) calling out a turnaround underway, and TD Cowen ($110 from $100) and Needham ($114 from $101) both raised targets in the past week. Recent portfolio moves (completed acquisitions of SPR Therapeutics in pain therapy and Scientia Vascular in neurovascular access, plus an AI-enabled surgical compute platform unveiled on Nvidia infrastructure) are the qualitative story management will lean on alongside segment growth in Cardiovascular, Neuroscience, and Medical Surgical. The complicating wrinkle: Medtronic still owns roughly 88-90% of newly spun-off MiniMed (MMED), which reports its own first quarter as a public company the same morning — so Tuesday effectively delivers two looks at the same parent company's diabetes exposure within hours of each other.

MMED ($20.10) — first quarterly report since a discounted IPO. MiniMed Group, the diabetes-technology business Medtronic spun off via IPO on March 6, 2026 (priced at $20, below the $25-28 marketed range, raising $560M at a $5.6B valuation), reports its fiscal Q1 FY27 results before Tuesday's open — only its second earnings release as a standalone filer. The prior print (Q4 FY26, reported June 3 alongside the IPO-adjacent numbers) showed revenue of $837M against a $826.52M consensus — a beat — but non-GAAP EPS of -$0.68 against a -$0.22 consensus, a sizable miss, and Wells Fargo trimmed its target to $22 from $26 afterward even while staying Overweight. Since then the stock has recovered to $20.10 (+3.02% Friday, 52-week range $10.65-$20.88 — closing near the top of its post-IPO range), helped by product launches (the MiniMed Flex system, the smallest app-controlled pump in the lineup, now shipping in the U.S. and Europe with Abbott's Instinct sensor) and expanded Medicare access. Consensus for this print is described as roughly $0.09 non-GAAP EPS versus $0.35 a year ago on a pro forma basis; FY26 revenue came in above $3B with 8% organic growth, and management has guided to ~10% organic growth and EBITDA margin expansion for FY27. Analyst sentiment is Strong Buy (13 analysts) with a $20.83 average target, essentially in line with Friday's close.

NIO ($4.37) — deliveries missed guidance, margin trend is the offset. NIO reports Q2 2026 results before Tuesday's U.S. open (8 a.m. ET call). Consensus estimates cluster around a loss of $0.05-0.07 per ADS on revenue of roughly $4.78-4.95B, against a $0.28 loss and $2.63B revenue a year ago. The company already disclosed Q2 deliveries of 107,658 vehicles, up 49.4% y/y but below its own 110,000-115,000 guidance range, and July deliveries fell further, pressuring the stock to a 52-week low. NIO closed Friday at $4.37 (+0.23%), essentially sitting on its 52-week low of $4.30 (high: $8.02) — the stock is down roughly 45% from its 2026 peak. The offsetting story is margin trajectory: Q1 2026 vehicle margin was 18.8% (a fourth straight quarterly improvement, versus 10.2% a year earlier), and NIO posted a second consecutive quarter of non-GAAP operating profit (RMB 66.8M). Management's full-year target is a 17-18% vehicle margin. Short interest has actually been falling (~8.2% of float, down recently) even as the stock has dropped, and the analyst consensus remains Buy with a $7.37 average target — a striking ~69% gap to Friday's close that underscores how far sentiment and price have diverged into this print.

YEXT ($6.91) — a sharp recovery off a post-Q1 low. Yext reports fiscal Q2 FY27 results Tuesday (session placement per Carl's calendar; see Flagged section on timing). The prior quarter was rough: Q1 FY27 revenue missed and the stock fell 18% to $3.45 same-day, with B. Riley downgrading to Neutral (target cut to $5 from $8) on what it called "subpar fundamentals" beneath a mixed report; management also suspended guidance after Q4. Since then shares have rallied back to $6.91 (+2.22% Friday, 52-week range $3.27-$9.20), roughly doubling off the post-Q1 low, coinciding with Yext's repositioning around "agentic marketing" — a Scout MCP/API launch opening its visibility and competitive-intelligence data layer to AI agents and partners. It's a small-cap story (market cap $692.7M, TTM revenue $445M, forward P/E 10.2x) with thin, dated sell-side coverage — no current aggregate price target was available — so the print carries elevated headline risk in either direction after a quarter that has already re-rated the stock meaningfully higher.

Tier 1 — after the close

CRDO ($232.75) — the hyperscaler-connectivity read on whether AI infrastructure commoditizes. Credo Technology reports fiscal Q1 FY27 after Tuesday's close (2 p.m. PT call). Consensus is $1.16 EPS (+123.1% y/y) on $470.7M revenue, against company guidance of $465-475M — guidance that already sits above the Street number. Credo has beaten estimates in each of the last four quarters by an average surprise of 27.4%, and FY26 revenue more than tripled to $1.34B; FY27 guidance calls for over 80% growth with optical products contributing more than $600M. The stock closed Friday at $232.75 (-3.12%), down more than 20% from its late-June peak of $308.67 — JPMorgan called the pullback an "attractive setup," noting Credo "screens inexpensive relative to most AI suppliers" given the selloff. This is one of the more direct tests of Carl's AI-infrastructure-commoditization thread: Credo's active electrical cables and optical transceivers sit in hyperscaler and neocloud connectivity backlogs, and the company is pushing to standardize an interconnect (OmniConnect) within the Open Compute Project to address the AI-inference "memory wall" — a bid to entrench itself as a standard rather than a commodity part. Mizuho named Credo (alongside NVDA and DELL) one of its preferred AI-buildout plays tied to a reported $500B financing wave in data-center capex.

DELL ($456.24) — the AI-server margin question, at scale. Dell Technologies reports fiscal Q2 FY27 after Tuesday's close (conference call 3:30 p.m. CDT). Consensus is $4.92 EPS (+112% y/y) on $44.51B revenue (+50% y/y), consistent with Dell's own guide of $44-45B and management's expectation that the Infrastructure Solutions Group (servers/storage) grows roughly 75% on AI-server demand. The stock closed Friday at $456.24 (-3.39%), still up roughly 260% over the past year and 235% year-to-date, inside a 52-week range of $110.22-$514.00 — a run that puts a high bar on the print per multiple sell-side previews. Target raises have been aggressive into the quarter: Evercore ISI to $550 from $500, Wells Fargo to $545 from $505, UBS to $455. Dell shares also jumped 9% in July on Super Micro's strong preliminary results, a read-through investors will look for again this week. This print is the other half of Carl's commoditization debate alongside CRDO: the question isn't whether AI-server revenue is growing — it plainly is — but whether ISG margins hold as volume scales and configurations standardize.

GTLB ($44.87) — a huge target-raise wave, but the average target still sits below the stock. GitLab reports fiscal Q2 FY27 after Tuesday's close. Consensus is roughly $0.18 non-GAAP EPS (management guided $0.17-0.18) on $273.1M revenue (guided $272-274M). The setup is unusual: at least eight sell-side firms raised price targets in the two weeks before the print (TD Cowen to $42 from $29, JPMorgan to $44 from $32, BofA to $45 from $38, RBC to $46 from $29, among others), yet the average target of $38.48 still sits about 14% below Friday's $44.87 close — the stock has out-run the Street's own upgrades heading into the report. FY26 revenue grew 25.8% to $955.2M; the 52-week range ($18.73-$52.38) shows a name that was down as much as 50% from its 2025 high before this recent rally. This is one of Carl's more direct AI-agents-vs-seat-based-software reads: GitLab is scaling its Duo Agent Platform and just published research (via Harris Poll) arguing organizations are "generating AI code faster than they can control it" — positioning itself as the governance layer for agentic coding rather than a per-seat DevOps tool, a framing the market will test against the actual net-new ARR mix Tuesday.

MDB ($446.62) — Atlas growth versus a wall of raised targets. MongoDB reports fiscal Q2 FY27 after Tuesday's close (5 p.m. ET call). Consensus is $1.62 EPS; the company's own guide calls for $729-734M revenue (+23-24% y/y). Q1 FY27 (reported ~June) showed Atlas growing 29% and now representing 75% of total revenue, with a beat-and-raise result — but Barclays flagged that Atlas growth "did not accelerate meaningfully" versus Datadog and Snowflake, calling it "a small negative" against elevated expectations. That same tension defines this print: FY27 full-year guidance implies only ~15% total revenue growth and ~21% Atlas growth for the back half, which some desks read as conservative "room to beat," while others see deceleration risk. The stock closed Friday at $446.62 (+1.37%), near its 52-week high of $473.10, up 72% over the past year. Target hikes have been extreme heading in — Wells Fargo to $575 from $375, Guggenheim to $560 from $475, Citizens to $519 from $366 — yet the $441.69 average target is essentially at Friday's spot price, meaning expectations are already fully baked in. MongoDB is also pitching itself directly into the AI-agent thread, having shipped a Managed MCP Server connecting Claude Code, Codex, Grok Build, and Devin to Atlas — positioning its database as the memory/context layer for agentic coding tools.

PANW ($371.59) — riding a CrowdStrike-driven rally into its own fiscal-year close. Palo Alto Networks reports fiscal Q4 and full fiscal-year 2026 results after Tuesday's close (4:30 p.m. ET webcast). Consensus is $3.35B revenue (+32.1% y/y) and $0.98 non-GAAP EPS (+3.2% y/y), matching the top end of management's own $3.34-3.35B / $0.96-0.98 guide. The stock closed Friday at $371.59 (-2.94%), off its August 13 all-time high of $398.88 but still up 110% over 52 weeks; shares had jumped as much as 14% earlier in the week on a read-through rally after CrowdStrike's own Q2 beat lifted the whole cybersecurity group (CRWD, ZS, RBRK, NTSK all rallied with it) — meaning PANW walks into its print already trading rich off someone else's good news. Target raises have been substantial: Jefferies to $450 from $335, Cantor Fitzgerald to $425 from $340, Mizuho and BMO both to $415; still, the $364.01 average target sits modestly below Friday's close. Also notable for the platformization thread: reporting suggests Palo Alto explored acquisitions of Datadog and Okta before talks fell apart, part of CEO Nikesh Arora's push to consolidate point-security tools (Prisma, Cortex, Strata) into a single platform and to extend into AI-agent security (Prisma AIRS, the new Frontier AI Critical Defense Program).

The rest, by cluster

• Government/defense services (Mon): SAIC — see monday_am.md.
• Medtech/diabetes (Tue AM): MDT and its MMED spinoff both report the same morning — a rare same-day, same-parent-company double read.
• China EV (Tue AM): NIO — delivery guidance miss and margin-improvement narrative both intact; see Tier 1.
• Small-cap software (Tue AM): YEXT — thin coverage, high headline volatility given the post-Q1 round trip.

Where the asymmetries sit (landscape, not advice)

• NIO: consensus rating (Buy, $7.37 target) sits nearly 69% above Friday's $4.37 close — one of the widest analyst-versus-price gaps in this group, with short interest actually falling even as the stock sits at a 52-week low.
• GTLB and PANW: both walk into their prints with Friday's closing price already above the Street's own average target, despite a wave of target hikes in the two weeks prior — a setup where "in-line" results could still disappoint a bar that's been raised mostly by price action, not estimate revisions.
• MDB: average target ($441.69) is essentially at the stock ($446.62) — the print needs to clear an unusually high, fully-priced-in bar, with Atlas deceleration the specific swing factor flagged by Barclays.
• CRDO: down >20% from its late-June high heading into a quarter where its own guidance already sits above consensus — a setup some desks (JPMorgan) are calling washed-out relative to peers.
• MMED: thin float (Medtronic still owns ~88-90% of shares), only its second print as a public company, and last quarter's non-GAAP EPS miss was large (-$0.68 vs. -$0.22 consensus) even as revenue beat — a name where the print's internals (not the headline) will matter most.

Dominoes

Tuesday's after-the-close results chain directly into the rest of the week's calendar. DELL and CRDO — both AI-infrastructure hardware/connectivity names — set up direct read-throughs into Wednesday's AVGO and HPE reports, where the same AI-capex-versus-margin questions will be re-litigated. PANW's results (and Tuesday's CrowdStrike-driven rally in the group) feed directly into Thursday's ZS print, with the whole cybersecurity-platformization debate carrying over. GTLB and MDB, both DevSecOps/data-infrastructure names touching the AI-agent thread, set up the broader Thursday software slate, where the market will be looking for confirmation (or denial) of the agentic-software narrative both companies leaned on this week. Tuesday's JOLTS data also sets the stage for Wednesday's ADP and Friday's jobs report, all now read through the more hawkish rate lens Warsh introduced Friday.

Flagged as unverified

• NIO is a foreign private issuer and 6-K filer (confirmed via SEC EDGAR filing history) — any EDGAR-based automated watcher built for 10-Q/10-K/8-K filers will not catch its earnings filing; this needs to be sourced from NIO's own press releases/6-K exhibits directly.
• MMED (MiniMed Group) — contrary to the working assumption that it, like NIO, might be a foreign private issuer, MiniMed appears to be a standard U.S. domestic filer: it has filed a 10-K (FY26 annual report) and DEF 14A-style proxy statements, and it IPO'd on Nasdaq as a Delaware/U.S.-registered spinoff of Medtronic. This should mean a standard EDGAR watcher (10-Q for this quarter) will catch it — flagging for Carl to confirm filer status directly, since this contradicts the initial assumption in the brief.
• YEXT's exact reporting session (before-the-open vs. after-the-close) was not independently confirmed beyond the calendar placement supplied; company press releases described the date (September 1) but not explicitly the time of day. Treat the "before the open" placement as per Carl's calendar, unverified against a primary source.
• SAIC/MDT/NIO/MMED/CRDO/DELL/GTLB/MDB/PANW timing (AM vs. PM) was otherwise cross-checked against at least one earnings-calendar aggregator plus, in most cases, a company press release or investor-relations page; PANW, CRDO, DELL, GTLB, and MDB's after-the-close placement is well-corroborated across multiple sources.
• Several consensus figures (SAIC's exact Q2 EPS/revenue; MMED's exact EPS consensus; NIO's exact revenue consensus, which ranged $4.78-4.95B across sources) come from earnings-preview aggregations rather than a single named data provider (FactSet/Visible Alpha/Zacks were cited inconsistently across sources) — treat precise decimal figures as directional rather than exact.
• Short-interest percentages cited for SAIC and NIO did not carry consistent as-of dates across sources and could be several weeks stale.

*Sources: stockanalysis.com, TipRanks (earnings calendars and news for MDT/NIO/MMED/PANW/GTLB/MDB/CRDO/YEXT), SEC EDGAR (NIO 6-K and MMED 10-K/proxy filings), Zacks via TradingView and Barchart, GlobeNewswire and BusinessWire and PRNewswire (company earnings-date press releases), CnEVPost, The Motley Fool, Investopedia, MarketWatch, Barrons, CNBC, NPR, Bitcoin.com News (Warsh/FedWatch), all accessed 8/30/26.

Wednesday 9/2 — Desk Preview

Prepared Sunday 8/30/26. Landscape only, no recommendations.

The frame

Stocks limped into the long weekend: S&P 500 7,711.76 (-0.25% Friday, +0.5% on the week), Nasdaq 26,402.42 (-0.52%, +0.9% wk), Dow 53,559.99 (flat). Fed Chair Kevin Warsh's first Jackson Hole keynote landed hawkish — inflation "running too high" — and September hike odds spiked to roughly 57%. That's an unusual backdrop for a week this loaded with AI capex data: JOLTS Tuesday, ADP Wednesday morning (hours before AVGO's tape), and the August jobs report Friday 9/4 (consensus +58K, unemployment 4.1%, average hourly earnings +0.3%). A hot jobs print into a hawkish Fed is the tail risk bracketing every one of these earnings reactions.

The AI-hardware setup is the story. NVDA reported Wednesday 8/26: revenue $96.2B (+106% y/y, ~4.5% beat), EPS $2.22, guide roughly 4% above Street — and the stock fell for a fourth straight post-print session. The Philadelphia Semiconductor Index (SOX) has now shed as much as 29% from its late-June record. The tape's message has been consistent for a month: it sells beats-with-blemishes and pays only for clean raises. Every AI-infrastructure name reporting this week — AVGO most of all — gets read through that lens. Estimated industry AI capex tops $1T this year (+~111%), with hyperscaler capex +~98%; the question isn't whether the spending is happening, it's whether this week's prints show it decelerating, and whether guidance is "clean" enough to survive the tape's current mood. It's also a full trading week ahead of Labor Day (9/7), so light pre-holiday volumes could exaggerate moves in either direction.

Tier 1 — before the open

GIII ($33.46) — momentum name walking into a tougher setup than the stock price shows. G-III reports Wednesday before the open (confirmed via the company's own 8/26 release, correcting an earlier "Sep 3" date seen in some trackers). Q1 FY27 beat with $536M sales and gross margin up 350bps y/y, and management raised full-year EPS guidance to $3.85–$3.95; Q2 guide is net sales near $570M and EPS $0.15–$0.25. The Marc Jacobs joint venture with WHP Global (an $850M carve-out from LVMH) is now integrating and is the mix-shift story — owned brands over lower-margin licenses. Stock sits near its 52-week high ($37.54) on a 3-analyst Buy consensus and a $39.33 target.

OLLI ($72.42) — steady operator, brutally de-rated stock. Ollie's reports before the open. Consensus: EPS $1.14 (+15.2% y/y), revenue $757.86M (+11.5%), with comps guided to just +0.3% against a tough +5.0% prior-year comp and only 15 new stores estimated versus 29 a year ago — a visible deceleration signal analysts are already pricing. What stands out is the wall of price-target cuts into the print despite still-positive growth: UBS to $85, Citi to $100, Piper Sandler to $113, Wells Fargo to $100, RBC to $121, KeyBanc to $98, Truist to $80 — all in the past two months, with JPMorgan explicitly citing "sees Q2 miss" in its downgrade to Neutral seven weeks ago. The stock trades 48% below its 52-week high of $140.17 on a modest 17.9x trailing multiple, the starkest value-versus-growth split in the off-price group against Five Below below.

CXM ($8.16) — cheap, AI-pivoting, guided conservatively. Sprinklr reports before the open. Q1 FY27 beat (EPS 11c vs 10c consensus, revenue $219.5M vs $215.91M, +7% y/y), but the company's own Q2 guide (EPS 10c vs 12c consensus, revenue $214–215M vs $215.47M consensus) sits at or slightly below Street, and FY27 guidance (EPS 48–49c, revenue $866.5–868.5M) also lands roughly in-line to slightly light. New CRO Thomas Addis and a new board seat for Microsoft's Search & AI president Jordi Ribas, plus fresh AI features (LLM Insights, Summer '26 release, the ViralMoment acquisition) are the AI-native pitch for a stock trading at 16x forward earnings — cheap if the AI story sticks, a show-me name if it doesn't. Analyst consensus is Hold with an $7.88 target essentially at the current price.

BF.B ($27.22) and OLLI anchor the pre-market slate alongside two smaller names — see clusters below for BF.B's Sazerac-bid and CEO-transition overhang.

Tier 1 — after the close

AVGO ($368.79) — the week's anchor, and the single most important AI-capex datapoint on the calendar. Broadcom reports Wednesday after the close. Consensus: revenue near $29.4B (guided 84% y/y growth) and non-GAAP EPS around $3.24, roughly double last year's $1.69. AI semiconductor revenue is guided to $16B for the quarter (+200%+ y/y), building on Q2's $10.8B (+143% y/y, above forecast) on a consolidated Q2 revenue base of $22.2B (+48% y/y) — implying a sizable sequential AI-revenue acceleration if the guide holds. Six named custom-ASIC/XPU customers (Anthropic, Google, Meta, OpenAI among them) anchor the backlog story, full-year AI semi revenue is guided to $56B (+180%), and management has reiterated an FY27 AI semiconductor target above $100B. Broadcom is also reportedly seeking $60–80B (some reports say up to $100B) in AI debt financing tied to chip purchases for Anthropic and others, mirroring NVDA's financing push. The stock is down roughly 25% from its 52-week high ($495) to $368.79, and Cathie Wood's ARK has been buying into the print even as the stock closed lower Friday. RBC (Sector Perform, $400 target) expects "a slight beat and raise" but flags gross-margin and TPU-share scrutiny after Google expanded its Marvell relationship — the custom-ASIC-vs-merchant-GPU debate Carl has been tracking plays out directly in this print. Given the tape's post-NVDA mood, the backlog commentary and the cleanliness of any raise likely matter more than the headline beat itself.

SNOW ($328.00) — consumption-model counter-read to AI-agents-displaces-seats. Snowflake reports after the close. Product revenue guide for the quarter is roughly $1.42B (raised off a strong Q1 beat of $1.33B), with full-year product revenue guided to $5.84B (+31%). Consensus estimates for the quarter carry some spread depending on source (EPS estimates as low as $0.26 and as high as $0.45 have circulated — flagged below). The stock sits near its 52-week high ($341.95) after a wave of price-target increases into the print (UBS to $425, BofA and Citi to $395, Oppenheimer to $400, Jefferies to $385) on channel checks showing "accelerating AI-driven demand." New AI infrastructure (Cortex AI Gateway dynamic model routing, announced 8/18) reinforces the consumption thesis Carl has flagged as the counter-case to seat-based software being disrupted by agents — Snowflake's model charges for usage, not seats, so AI adoption is upside rather than a threat. A guidance cut or deceleration here would be read as evidence against that thesis at a stock already priced for a clean beat.

HPE ($52.31) — AI infrastructure demand still strong, but Friday's -3.86% drop shows the market isn't giving it credit yet. HPE reports after the close. Guidance calls for revenue of $11.5–12.1B (Zacks consensus $12.1B, +32% y/y) and non-GAAP EPS of 88–93c (Zacks consensus 94c, +113.6% y/y). Last quarter (Q2 FY26, reported June 1) was a clean beat-and-raise: revenue $10.68B (+40% y/y) against a $9.74B consensus, EPS $0.79 (+108%), AI systems orders of $1.8B driving a record backlog, and networking revenue of $2.69B (versus $1.08B a year ago) as the Juniper integration scales — a federal court affirmed the DOJ settlement clearing that deal on 8/13. Morgan Stanley upgraded to Overweight on 8/10 citing durable server-and-storage spending. The stock is still 19% below its 52-week high of $64.25 despite the AI tailwind, and this print is a direct read on the "commoditization tape" Carl has been tracking — whether server/storage margins hold up as AI infrastructure scales, and how SMCI's legal overhang factors into competitive server pricing.

NTAP ($187.02) — guided above consensus on both lines, storage-margin bellwether for the memory-cost thread. NetApp reports its fiscal Q1 2027 after the close. Company guidance (EPS $2.05–2.15, revenue $1.75–1.90B) sits comfortably above Street consensus ($1.84 EPS, $1.67B revenue), and full-year guidance ($8.70–9.00 EPS, $7.33–7.58B revenue) also tops consensus. Recent bolt-on M&A (JetStream Software for VMware disaster recovery, DataPelago for AI data infrastructure) signals NetApp positioning its storage franchise as AI-data-pipeline infrastructure rather than commodity disk. Big pre-print target hikes (Evercore to $210 from $170, Citi to $209 from $150) reflect that optimism, though the average target ($187.56) is now barely above the stock's own price. Goldman named NetApp one of its "top three U.S. hardware picks" alongside Dell and HPE. This is the print to watch for memory-cost commentary (Micron-adjacent) reading through into storage gross margins — the commoditization-versus-differentiation debate in miniature.

AI ($10.53) — the outlier: shrinking, not growing, and the only Sell-rated name in this group. C3.ai reports its fiscal Q1 2027 after the close, its first full quarter with founder Thomas Siebel back as CEO (he resumed the role May 8, 2026, after Stephen Ehikian had led the company since September 2025; Ehikian now remains as President). Guidance calls for Q1 revenue of just $50–54M against a non-GAAP operating loss of $40.5–48.5M, and full-year FY27 revenue guidance of $210–240M sits flat-to-down against FY26's actual $250.27M — a striking contrast to every growth name elsewhere in this preview. Headcount has been cut from roughly 1,075 in January to about 700, with ~$130M of a planned ~$160M in FY27 savings already realized. The stock trades 48% below its 52-week high, with the sell-side's average rating at "Sell" and a $8.82 target below spot. This is the cautionary case inside Carl's AI-agents-vs-seat-based-software thread: an "agentic pivot" story where the top line is still contracting, the opposite of Snowflake's consumption-growth counter-read.

FIVE ($241.89) — momentum retailer near highs, split analyst opinion on how much more room there is. Five Below reports after the close. Consensus: EPS $1.28 (+58% y/y), revenue $1.21B (+17.9%), building on a Q1 that delivered 33% sales growth and 158% EPS growth and prompted a raise in full-year adjusted EPS guidance to $8.65–9.05 from $7.74–8.25. Multiple firms lifted targets into the print this week (Telsey to $280, Mizuho to $278, Truist to $273), but Loop Capital downgraded to Hold on valuation just days ago even with an unchanged $250 target, while Bernstein moved the other way to Outperform. The stock sits near its 52-week high of $263.88, up roughly 90% over the past year — a name where the fundamental momentum and the "already priced in" debate are colliding directly into the print.

PVH ($75.79) — expectations reset after a guidance cut, deeply discounted valuation, split sell-side. PVH reports after the close. Consensus for the quarter is EPS $3.08 (+22.2% y/y) on revenue of $2.1B — a projected 3.2% y/y revenue decline. That follows a Q1 print in June that beat on both lines but came with a full-year revenue guidance cut to flat (from a prior slight-increase outlook) citing the Iran war's impact on EMEA sales; the stock fell over 20% that day and full-year net income has since collapsed to $25.30M from roughly $630M a year earlier. The stock is 25% below its 52-week high, trades at just 6.2x forward earnings, and a new CFO (Alexis Rollier) starts in early September — timing that lands right in earnings week. JPMorgan (Underweight, $84 target) and BofA (Underperform, $70 target) have both downgraded on estimate and EMEA-exposure risk, even as the broader 13-analyst consensus stays at Buy — one of the more genuinely split setups in this preview.

NTSK ($15.09) — second quarterly report as a public company, riding a cybersecurity-sector tailwind into the print. Netskope reports its fiscal Q2 2027 after the close (IPO'd September 2025; this is its second quarter as a public company, not its first as sometimes characterized). Q1 delivered ARR +29% y/y to $845M and revenue +28% y/y, beating guidance and prompting a full-year raise to $879–883M (versus $874.9M consensus). Q2 guidance of $213–215M (+25–26% y/y) sits modestly below the ~$218.47M Street consensus — a conservative bar. The stock has rallied roughly 75% since mid-June, prompting downgrades from Mizuho and Deutsche Bank on valuation even as JPMorgan, RBC, KeyBanc, Wells Fargo, BTIG and Oppenheimer all raised targets (as high as $19). Cybersecurity peers rallied hard three days ago after CrowdStrike's results lifted the group (PANW +10%), and Netskope's new Amazon Bedrock AgentCore integration ties it into the agentic-AI-security angle of Carl's AI-agents thread.

AGX ($417.74) — the power-bottleneck read, and it just had a violent, unexplained pre-earnings air-pocket. Argan reports its fiscal Q2 2027 after the close. Friday's session alone saw the stock fall 9.18%, extending a run of sharp single-day drops over the past two months (-10.1% and -7.3% on separate days) that have taken the stock 48% off its 52-week high of $805.75 — even though it remains up 193.5% over the full 52 weeks. Q1 FY27 (reported June 4) was a blowout: record revenue of $290.95M against a $256.03M consensus, EPS of $3.24 versus $2.33 expected, and a robust $2.8B backlog. Argan is a pure-play power-sector EPC/construction name (engineering, procurement and construction for large-scale power projects) — the clearest read in this entire slate on whether the AI-data-center power buildout is intact or losing steam. Analyst consensus remains Buy with a $667.80 target, but that target likely predates the recent selloff, and the scale of Friday's drop into the print is itself a signal the market is repricing something about the backlog or cost picture ahead of the numbers.

The rest, by cluster

Retail, before the open: Alongside GIII and OLLI above, this cohort chains directly into Thursday's LULU print — a full read on both value/off-price (OLLI, FIVE) and branded apparel (GIII, PVH) demand heading into back-to-school and holiday positioning.

Spirits, before the open — BF.B ($27.22): Brown-Forman reports fiscal Q1 2027 at 8am ET. Consensus EPS is $0.38 (+5.6% y/y), with full-year consensus at $1.71 (+11.8%) against management's own guide of flat organic net sales and a 3–5% decline in organic operating income — a margin-pressure story even as the top line holds. Two items dominate the setup: Sazerac's unsolicited ~$15B takeover approach, which Brown-Forman's board called "not actionable" on July 26 (Sazerac has since sent a letter urging the Brown family to reconsider), and CEO Lawson Whiting's mid-July retirement announcement with no successor yet named. Layer on freshly escalated 50% U.S. tariffs on Canadian alcohol this week in the ongoing trade dispute, and this print carries more corporate-action noise than fundamentals signal. Stock down 25% over 52 weeks, Hold consensus, 3.4% dividend yield.

Pet retail, after the close — WOOF ($2.70): Petco reports Wednesday afternoon. Consensus is essentially breakeven — EPS $0.01, revenue $1.4929B — with company guidance calling for "modest" net sales growth and adjusted EBITDA of $110–112M. Q1 marked a return to positive comps after a stretch of declines, the inflection narrative underpinning the stock's still-depressed $771M market cap (down ~77% since its 2021 IPO). Hold consensus, $3.54 target implies 31% upside from a very low base.

Healthcare tech, after the close — PHR ($11.38 as of the most recent verified close; flagged as potentially stale, see below): Phreesia reports fiscal Q2 2027 after the close. The company cut full-year FY27 revenue guidance sharply in late May, to $510–520M from a prior $545–559M, while holding its adjusted EBITDA outlook at $125–135M — guiding for materially slower growth but defending margins. Consensus sits at $515.9M revenue and $0.32 EPS for the year. The stock fell roughly 7% on the guidance-cut news and is the smallest-cap name in this week's slate; watch for follow-through commentary on why the top-line reset happened and whether it's stabilized.

Where the asymmetries sit (landscape, not advice)

AVGO carries the most binary setup of the week: a 40%+ gap between spot ($368.79) and the average analyst target ($525.97) reflects genuine backlog conviction, but the stock is already down 25% from its highs in a tape that punished NVDA's own beat-and-raise four sessions running — the bar for "clean" is unusually high. SNOW sits at the opposite extreme: priced near its 52-week high after a wall of pre-print target increases, meaning a beat may already be assumed and a merely in-line quarter could disappoint relative to expectations rather than absolute numbers. OLLI is a value-versus-momentum split within the same sub-sector as FIVE — the market has de-rated Ollie's by nearly half over the year on decelerating comps while paying up for Five Below's momentum, a divergence Wednesday's prints could either confirm or compress. AGX had its asymmetry front-loaded by Friday's -9% move — whatever was driving that repricing (broad market de-risking into a hawkish Fed, sector-wide power-name profit-taking, or something print-specific) will either be validated or reversed within 24 hours of the report. C3.ai's setup is the mirror image of the rest of the group: a Sell-rated stock guided to shrink, where the bar is low enough that even modest stabilization commentary could move the stock more than the still-negative headline growth number.

Dominoes

Tuesday-night reactions in DELL (reports Tuesday 9/1), CRDO and PANW set the tone before Wednesday's open — a soft AI-hardware or networking read Tuesday night raises the stakes on AVGO/HPE/NTAP Wednesday afternoon. Those three, in turn, chain into Thursday's CIEN and ZS/software slate: networking and AI-infrastructure commentary from AVGO and HPE Wednesday will be read directly against Ciena's optical-networking numbers and Zscaler's security-spending commentary Thursday. On the retail side, Wednesday's full slate — BF.B, GIII, OLLI, FIVE, PVH, WOOF — sets up Thursday's LULU print; a strong or weak consumer read across value retail, branded apparel and spirits Wednesday will color how the market treats Lululemon's numbers a day later.

Flagged as unverified

• GIII timing: One cached tracker (MarketBeat) listed G-III's earnings date as September 3; the company's own August 26 press release confirms results before the market open on September 2. Treated as September 2 BMO per the primary-source release.
• SNOW timing/price conflict: One search result claimed Snowflake "reported Q2 earnings August 27, 2026" with a resulting close of $238.66. This directly conflicts with stockanalysis.com's own earnings-date field (September 2, 2026) and its Friday 8/28 close of $328.00, which shows no earnings-reaction pattern. Treated as an erroneous/stale source; September 2 AH is used throughout.
• SNOW EPS consensus spread: Figures as low as $0.26 and as high as $0.45 both surfaced for the quarter's non-GAAP EPS consensus; neither could be independently confirmed as the authoritative Street number.
• AVGO revenue-guide magnitude: The cited Q3 FY26 consolidated revenue guide of ~$29.4B (84% y/y growth) implies a roughly 32% sequential jump from Q2's $22.2B — a large one-quarter acceleration. The figure appeared consistently across two independent search results but could not be cross-checked against a third source in this pass.
• PHR price/market cap: The only verifiable dated snapshot found was August 17, 2026 ($11.38, $703.42M market cap); a confirmed Friday 8/28 close could not be located. Used as an approximate reference only.
• AGX Q2-specific consensus: No specific EPS/revenue consensus figures for the fiscal Q2 2027 quarter itself could be located (only the Q1 print and full-year backlog data); the note relies on backlog and prior-quarter trend rather than a Q2 consensus number.
• No foreign 6-K filers identified among the fifteen Wednesday tickers — all appear to be domestic 10-Q filers.

Sources: stockanalysis.com, Broadcom investor relations (businesswire/prnewswire releases), HPE newsroom and investor relations, NetApp investor relations, C3.ai investor relations and stockanalysis.com filings, Five Below/Ollie's/PVH/G-III/Petco/Brown-Forman/Argan/Sprinklr/Netskope/Phreesia investor-relations press releases, TipRanks, TheFly (via TipRanks), Seeking Alpha, Zacks (via Yahoo Finance/TradingView), Reuters, WSJ, Barron's, CNBC, accessed 8/30/26.

Thursday 9/3 — Desk Preview

Prepared Sunday 8/30/26. Landscape only, no recommendations.

The frame

Friday 8/28 closes: S&P 500 7,711.76 (-0.25% Fri, +0.5% wk), Nasdaq 26,402.42 (-0.52%, +0.9% wk), Dow 53,559.99 (flat). The tape enters the week with a hawkish overhang: Fed Chair Kevin Warsh's first Jackson Hole keynote leaned hard on "inflation running too high," and September hike odds jumped to roughly 57% — a hike, not a cut, is now the live debate. NVDA's 8/26 print is the template for how this market is pricing AI names into Thursday: revenue $96.2B (+106% y/y, ~4.5% beat), EPS $2.22, guidance ~4% above Street — and the stock still fell for a fourth straight session, with the SOX off as much as 29% from its late-June record. The lesson for Thursday's software and hardware reporters: beats-with-blemishes get sold, and only clean, unambiguous raises get paid. It's a full trading week (Labor Day 9/7 falls the following Monday), and it ends not with an earnings report but with the August jobs number Friday morning (consensus +58K, 4.1% unemployment) — the macro finale that Thursday's dominoes effectively hand off to.

Thursday 9/3 is the single busiest print day of the week: 21 names across before-the-open industrials/consumer names, after-the-close software/tech, and two TBD-session names whose actual dates turned out not to be Thursday at all (see Flagged as unverified). The dominant analytical thread of the day is AI-agents-vs-seat-based software — ZS, DOCU, PATH, ASAN, GWRE and IOT all sit on it, with net-revenue-retention and seat-count commentary as the tell for whether the market believes the agentic pitch or is still paying for classic per-seat SaaS. A secondary thread runs through CIEN (optical/DCI backlog as hard evidence of AI-network capex, not just capex promises) and AMBA (edge AI, plus a live NXP take-out rumor). A third thread is consumer health — LULU (tariffs, China, CEO transition), RH (housing-linked luxury, though see the date flag), DOO (powersports), CPB (packaged food deflation-turned-inflation).

Tier 1 — before the open

CIEN ($378.44) — the AI-optical bellwether reports into a stock already up over 5x in a year. Consensus for fiscal Q3 sits at EPS $1.73 (+158% y/y) on revenue of $1.64B (+34.6% y/y), against management's own guide of $1.625B ± $50M — so the Street is already above the midpoint of guidance. Ciena ended fiscal Q2 with a $7.7B backlog, up over $600M sequentially, roughly $6.4B of it hardware with ~80% expected to ship within 12 months — real, contracted AI-network capex, not a promise. The stock is down over 40% from its 52-week high of $637.51 even after 20 analysts rate it Buy with a $557 average target, and it fell 5.35% on Friday alone; multiple sell-side desks (BofA, TD Cowen) trimmed price targets into the print even while staying bullish, a sign the market wants to see backlog conversion, not just backlog growth, this time.

DOO ($61.91) — BRP reports before the North American open with earnings already guided sharply lower. Management's own framing for fiscal Q2 is a normalized diluted EPS decline of roughly $1.60–$1.65 versus last year, driven by tariffs, PWC shipment timing, and the loss of last year's tax incentives; full-year guidance was cut to revenue of $9.1–$9.4B and normalized EPS of $3.00–$3.50. North American powersports retail sales were down 7% y/y in the most recent read, partly a comp against a strong snowmobile close last year. The setup is a name where the bar has already been lowered twice — the question Thursday is whether the reset guide holds or needs cutting again, and BRP is a Canadian foreign private issuer that reports via press release/6-K rather than the standard 8-K, so headline timing can differ from the U.S. calendar (see Flagged as unverified).

CPB ($23.39) — Campbell's closes out a rough fiscal year with consensus already braced for a 35% EPS decline. Fiscal Q4 consensus is EPS of $0.40 versus $0.62 a year ago; full-year guidance calls for organic revenue down 1–2% and adjusted EPS of $2.15–$2.25. The prior quarter (Q3) saw organic sales down roughly 4% in both Meals & Beverages and Snacks, with adjusted EPS down 32% as inflation, tariffs and softer volumes compressed margins simultaneously. The stock pays a 6.7% dividend yield and trades at 11.5x trailing earnings — cheap on the surface, but 20 analysts rate it Hold with a $22 target essentially at the current price, and UBS keeps a Sell rating even after raising its target, which tells you where sell-side conviction actually sits.

Tier 1 — after the close

LULU ($120.81) — Lululemon reports with the stock at its lowest levels since 2018 and guidance already de-risked to a headline EPS collapse. Management's own Q2 guide is revenue of $2.45–$2.475B (down 2–3% y/y) and EPS of $1.76–$1.81, versus $3.10 a year ago — gross margin is guided down 410bps, with tariffs alone worth a 150bp hit. The stock is down roughly 68% from its 52-week high of $225.98 and jumped 5.05% Friday to $120.81, an unusual pre-print bounce (possibly short-covering — short interest was recently near 8.7% of float) that stands out against a flat-to-down broad tape that day. Layered on top of the numbers: a CEO transition (Heidi O'Neill takes over in September), the departure of both the Chief AI/Technology Officer and the communications chief in the past two weeks, and a China backlash over a promotional event — governance and brand-momentum noise arriving at the same moment as the worst guide in years.

ZS ($184.23) — Zscaler reports fiscal Q4 with guidance essentially matching consensus, which puts all the weight on the outlook. Company guidance is revenue of $875–$878M and EPS of $1.08–$1.09; Street consensus (~$877M revenue) sits right on top of that, so an in-line beat buys little goodwill in this tape. The setup is genuinely two-sided: Barclays, KeyBanc, Mizuho, Stifel, JPMorgan and BofA have all raised price targets into the print (targets clustered $192–$215) on the back of a strong cybersecurity read-through from PANW's 10% post-earnings pop Tuesday — but Evercore added ZS to its "Tactical Underperform" list the same week, arguing the move up is overdone. Zscaler sits squarely on the AI-agents-vs-seat-software thread; net-new ARR and any commentary on agentic security consumption models will matter more than the headline beat.

DOCU ($64.00) — DocuSign reports fiscal Q2 with heavy bearish options positioning already stacked against it. Guidance calls for revenue of $865–$869M (+8% y/y) and EPS consensus of $1.08; full-year guide is $3.490–$3.502B in revenue with 8.25–8.75% ARR growth. IAM (the AI-native agreement platform) was 12.6% of ARR as of Q1 — the number to watch for whether the AI-product transition is actually accelerating adoption or just relabeling existing e-signature revenue. BofA raised its target to $58 ahead of the print while keeping an Underperform rating — a split that captures the stock's problem: 21 analysts rate it Hold on average with a $57.52 target that implies downside from the current price, and heavy put volume (1,663 contracts, 1.1x normal) was flagged directionally bearish just days before the report.

PATH ($18.15) — UiPath reports fiscal Q2 as the most explicit agentic-automation-vs-RPO-seats name on the calendar. Guidance is revenue of $395–$400M and ARR of $1.929–$1.934B; Q1 delivered the company's first-ever GAAP operating profit, 17% revenue growth and 109% net-dollar retention. The stock sits near the bottom of its 52-week range ($9.20–$19.84) despite that operating inflection, and the average analyst target ($13.44, Hold) implies roughly 26% downside from Friday's close — a sign the market still isn't paying up for the "agentic orchestration" reframe over classic RPA. UiPath has also scheduled an Investor Day for September 22, so Thursday's print doubles as a preview of what management will lean on three weeks later; NRR and ARR-growth trajectory are the tells for whether the seat-to-agent transition is landing with enterprise buyers.

IOT ($41.87 approx.) — Samsara reports fiscal Q2 with guidance already set above the prior Street number. Management guided revenue of $482–$484M (+23–24% y/y), above the pre-guide consensus of roughly $479.9M, and full-year guidance calls for $2.005–$2.013B (+24%) with non-GAAP operating margin raised to 20%. That's a "clean raise" setup rather than a "beat-and-hold," which is the one shape of report this tape has actually rewarded post-NVDA. Samsara sits on the AI-agents-vs-seats thread through its physical-operations/IoT angle — connected-vehicle and asset data feeding into AI-driven safety and efficiency products — and 23 of 24 analysts rate it Buy with a $44.31 target, though the stock is still down roughly 14% over the past year.

AMBA ($70.63) — Ambarella reports fiscal Q2 with an active M&A rumor still hanging over the stock. Consensus is EPS of $0.17 on revenue of $109.9M against management's own $105–$111M guide; the company's $800M+ long-term agreement with Hanwha remains the headline growth catalyst on the edge-AI/physical-AI thesis. The stock spiked to $87.32 in late July on an FT report that NXP Semiconductors was in talks to acquire Ambarella, then drifted back into the $70s with the deal unconfirmed and un-updated — meaning Thursday's print lands with unresolved takeover speculation still priced in to some degree, on top of the fundamental edge-AI/DCI-adjacent story. AMBA sits alongside CIEN as the desk's two "AI infrastructure is real, look at the backlog/bookings" data points for Thursday.

ASAN ($10.19) — Asana reports fiscal Q2 with record-high short interest and guidance that already undershoots consensus on the bottom line. Management guided EPS of $0.08–$0.09 (below the $0.09 consensus at the midpoint) and revenue of $213–$215M; short interest recently hit a record 13.96% of float. The offsetting story is the "AI Teammates" launch — over 30 pre-built agents — plus the StackAI acquisition, expected to add roughly 50bps to growth; full-year guidance ($855.5–$863.5M) sits slightly above the $854.3M Street number even as the quarterly EPS guide undershoots. Asana is the cleanest small-cap read on whether "human-agent teams" positioning can offset decelerating seat growth — the most literal embodiment of Thursday's central thread.

GWRE ($205.85) — Guidewire closes fiscal 2026 with subscription revenue that grew 33% y/y last quarter and a stock near its highs. Q4 guidance is ending ARR of $1,048–$1,054M and revenue of $315–$321M; full-year guide is ARR of $1,210–$1,220M and revenue of $1,385–$1,405M. Guggenheim raised its target to $210 just three days before the print, and 16 analysts rate the stock Buy on average with a $204.57 target essentially matching Friday's close — a name priced for a clean beat-and-hold rather than a surprise. Guidewire's new "Qusar" release (claims/underwriting AI agents plus developer assistants) puts it on the agentic thread from the vendor side — insurers building agents on Guidewire's platform rather than replacing seats — worth watching for how management frames AI monetization on the call.

PL ($19.98) — Planet Labs reports fiscal Q2 after a rough Friday sell-off (-5.58%) heading into the print. Guidance calls for revenue of $102–$107M (~42% y/y growth) against a Street consensus around $104M; full-year guidance is $425–$441M (~41% growth). The stock is down roughly 50% from its highs since the SpaceX IPO reset comps across the space sector, even as 11 analysts rate it Buy with an average target of $40.10 — more than double Friday's close, one of the widest analyst-price-versus-spot gaps on the entire Thursday slate. Planet Labs is unprofitable and carries no meaningful PE, so the print is a pure growth-and-backlog story; a new Rwanda national data program announced in August is the kind of recurring-government-contract evidence bulls point to.

RH ($149.49) — flagged for timing: available data points to a September 10 report date, not September 3. Multiple sources (including direct IR-adjacent searches) show RH's Q2 fiscal 2026 results are scheduled for September 10, 2026 after the close — a full week after Carl's Thursday placement. If that holds, RH does not report Thursday at all. The fundamentals for context regardless: Q1 beat expectations and RH raised full-year guidance to revenue growth of 4.5–8.0% and adjusted EBITDA margins of 14.2–16.0%, with backorder/special-order balances running about $75M higher than a year ago on tariff-driven resourcing (a roughly $45M revenue drag from timing alone). RH carries heavy leverage (over 4x trailing EBITDA) and is a pure read on high-end housing-linked demand; the stock jumped 3.24% Friday to $149.49, still down nearly 42% from its 52-week high of $257.00.

The rest, by cluster

Industrial/consumer, before the open: TTC (Toro) carries a consensus of EPS $1.24 on revenue of $1.17B for fiscal Q3, coming off a quarter where sales rose 8.1% and adjusted EPS rose 13%; the company also just named a new CEO (Edric Funk succeeding Richard Olson) as part of planned succession. BRC (Brady) reports fiscal Q4 with the stock near 52-week highs after five straight quarters of EPS beats and a freshly closed $1.4B acquisition of Honeywell's PSS business — the integration commentary matters as much as the print. MOMO (Hello Group) guided Q2 revenue of $355.18–$369.67M; Q1 saw a 5% domestic revenue decline offset by 44% overseas growth, the now-familiar China-social-app pattern of domestic regulatory drag versus overseas expansion — MOMO is a China-based ADR filer and a likely foreign-private-issuer (see Flagged as unverified). WLY (Wiley) reports fiscal Q1 2027 off FY26 guidance of adjusted EPS $4.60–$5.05 and AI revenue scaling 2–3x from $8M to over $50M — a slow, profitable AI-monetization story in academic publishing. VSXY (Victoria's Secret) reports Q2 before the open with the stock up nearly 300% over the past year on a well-documented turnaround under CEO Hillary Super; JPMorgan and BofA both raised targets into the print (to $110 and $107 respectively), a genuinely bullish setup rather than a battleground one, though a activist stake from BBRC International (Brett Blundy, ~13%) adds a governance subplot.

Retail/industrial/defense, after the close: OXM (Oxford Industries, Tommy Bahama/Lilly Pulitzer) guided Q2 revenue of just $380–$400M against a Street consensus of $413.86M — a guide well below consensus, with adjusted EPS guided to $1.20–$1.40 versus a $1.46 consensus, so the bar has already been set meaningfully lower than where the Street started; tariffs and promotional pressure are the stated drivers, and the stock is down almost 40% over 52 weeks. SWBI (Smith & Wesson) reports fiscal Q1 with consensus actually forecasting a per-share loss (-$0.055) on revenue of roughly $98.7M — a seasonally soft quarter for the firearms maker after a strong FY26 (revenue +10%, EPS +38%); the stock is up over 50% in the past year on market-share gains.

Where the asymmetries sit (landscape, not advice)

The spread between analyst targets and spot price is unusually wide across several Thursday names, in both directions. PL's average target ($40.10) sits more than 100% above Friday's close — either the sell-side is early on a re-rating or the Street hasn't caught down to a stock that's already halved. PATH sits at the opposite extreme: a $13.44 average target implies roughly 26% downside from spot despite the company's first GAAP profit and 109% NRR, suggesting the market is demanding proof the "orchestration" pivot converts to durable growth before it will pay up. DOCU shows a similar disconnect — a $57.52 target below the current $64.00 price, with heavy bearish options flow layered on top, even as fundamentals (IAM at 12.6% of ARR, steady beats) look stable. On the other side, CIEN, ZS and GWRE are all priced closer to consensus fair value, which raises the bar for what a "good" print needs to look like — in-line numbers with a soft outlook are more likely to be sold than bought, consistent with the post-NVDA pattern of the tape punishing anything short of a clean raise. LULU is the starkest setup of the group: guidance already implies a 43% EPS decline, the stock trades near a 2018 low, and yet it bounced 5% on Friday — a market that may be positioned for "bad but not as bad as feared" rather than genuinely optimistic.

Dominoes

Wednesday night's AVGO, SNOW and HPE reactions set the tone for Thursday's opening tape across semis/AI-infrastructure (AVGO), cloud data/software (SNOW) and enterprise hardware (HPE) — all three print after Wednesday's close and will be digested before CIEN, DOO and CPB open Thursday morning. ZS follows directly on PANW's strong Tuesday reaction (shares +10%) and CRWD's results the same week, so Zscaler inherits a sector tape that's already been tested for how the market treats cybersecurity beats. LULU follows the broader Wednesday retail slate, so read-throughs on consumer spend, tariff pass-through and promotional intensity from other retailers reporting mid-week will frame expectations before Lululemon's own numbers land after Thursday's close. Friday 9/4 has no earnings reporters at all — the week's macro finale is the August jobs report instead (consensus +58K, +4.1% unemployment), meaning Thursday's after-the-close batch is effectively the last stock-specific catalyst before the tape pivots entirely to the labor data and what it implies for the September Fed decision Warsh has already signaled leans hawkish.

Flagged as unverified

• RH earnings date: Multiple sources place RH's Q2 fiscal 2026 report on September 10, 2026 (after close) — not Thursday, September 3, as listed in the source calendar. Carl's briefing.com-derived calendar may be using a placeholder or prior-year cadence; verify directly with RH IR before the week begins.
• KFY earnings date: Sources conflict — stockanalysis.com shows September 4, 2026 (which would be Friday, not Thursday); another source (MarketBeat) shows September 8, 2026. Neither is Thursday, September 3, and a September 4 date would directly contradict the note that Friday 9/4 has no reporters. Verify with Korn Ferry IR.
• MOMO (Hello Group) foreign filer status: MOMO is a China-based ADR (Cayman-domiciled) that reports via press release rather than a standard 8-K; an EDGAR 8-K watcher will likely miss or mistime this filing. Before-open timing (7:00 a.m. ET release, 7:00 p.m. Beijing call) is confirmed via company press release, but treat any automated filing-based calendar as unreliable for this name.
• DOO (BRP) foreign filer status: BRP is a Canadian company (TSX/NASDAQ dual-listed) that furnishes results via press release/Canadian-newswire distribution rather than a standard U.S. 8-K; same EDGAR-watcher blind spot applies. Timing (pre-market release ~6 a.m. ET, 9 a.m. ET call) is sourced from company press release but should be independently reconfirmed.
• WLY session timing: Wiley's Q1 FY27 date (September 3) is confirmed via company press release, but the specific before-open/after-close timing was not directly confirmed in this research; placed before-open per the source calendar, unverified against a primary release-time citation.
• IOT (Samsara) closing price: Friday 8/28 closing price ($41.87) is sourced from a same-week secondary reference rather than a same-day primary quote; treat as approximate.
• TTC (Toro) closing price: Price shown ($98.48) reflects a Friday mid-morning snapshot rather than the 4:00 p.m. close; directionally accurate but not an exact closing print.
• SWBI (Smith & Wesson) closing price: Most recent available quote is from August 25, 2026 ($13.51), not August 28; no confirmed Friday close was found.
• LULU Friday move: The reported +5.05% Friday gain to $120.81 is unusual against a flat-to-down broader tape and a deeply negative earnings setup; flagged for a sanity check against exchange data before publication, as it may reflect short-covering, an index-related flow, or a data artifact.

Sources: stockanalysis.com, businesswire.com, prnewswire.com, globenewswire.com, TipRanks/TheFly, Reuters, WSJ, Barron's, company press releases and investor-relations pages, accessed 8/30/26.